 |
|
If you need to get a quote for any product, or have any questions, please fill in the
following contact form, we will contact you within 24 hours. If your have an account with us, click here to login to retrieve your information.
| Your Contact Information (Required *) |
| First Name* |
|
| Last Name* |
|
| E-Mail* |
|
| Company Name* |
|
| Address |
|
| City |
|
| State |
|
| Zip |
|
| Country |
|
| Phone |
|
| Fax |
|
| Web Site |
|
| |
| Products Interested (Browsing products) |
|
| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-4396 |
21901-34-8 |
2-HYDROXY-3-METHYL-5-NITROPYRIDINE |
|
| A1-7276 |
38191-34-3 |
2-Amino-5-bromophenol |
|
| AS-0138 |
598-50-5 |
Methylurea |
|
| AS-1100 |
89-78-1 |
DL-Menthol |
|
| AS-1263 |
111-34-2 |
n-Butyl vinyl ether |
|
| AS-1829 |
74346-19-3 |
4-bromo-2,6-dimethylbenzoic acid |
|
| AS-1839 |
5402-60-8 |
2,6-Dimethylbenzyl chloride |
|
| AS-2013 |
3/9/1993 |
2-Fluorophenylboronic acid |
|
| AS-2047 |
40138-16-7 |
2-Formylbenzeneboronic acid |
|
| AS-2053 |
43192-33-2 |
4-BROMO-2-METHOXYBENZALDEHYDE |
|
| AS-2060 |
88569-83-9 |
2-Methoxy-6-(methylamino)pyridine |
|
| AS-2299 |
88-65-3 |
2-Bromobenzoic acid |
|
| AS-2301 |
70-11-1 |
2-Bromoacetophenone |
|
| AS-2306 |
80-58-0 |
2-Bromobutyric acid |
|
| AS-3826 |
41085-43-2 |
2-Bromo-3-nitrotoluene |
|
| AS-6121 |
2424-01-3 |
Methyldiallylamine |
|
| AS-6407 |
56239-26-0 |
4-aminocyclohexan-1-ol |
|
| AS-6410 |
125354-16-7 |
Docetaxel |
|
| AS-6420 |
460-35-5 |
3-CHLORO-1,1,1-TRIFLUOROPROPANE |
|
| AS-7016 |
32723-67-4 |
3-Methyl-4-anisaldehyde |
|
| AS-7170 |
117445-22-4 |
Boc-3-Aminomethylbenzoic acid |
|
| AS-7203 |
900254-47-9 |
Methyl 4-nitro-2-trifluoroMethylbenzoate |
|
| AS-7328 |
335654-06-3 |
2-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE |
|
| JR6-L2331 |
121929-87-1 |
Ethanone, 1-[(4R)-4-(1-methylethyl)-2-thioxo-3-thiazolidinyl]- |
|
| JR6-L2345 |
1085994-61-1 |
2-Thiazolidinethione, 4-phenyl-3-(phenylmethyl)-, (4S)- |
|
| JR6-L3147 |
1375062-75-1 |
[1,1'-Binaphthalen]-2-ol, 2',6'-dimethoxy-3-methyl- |
|
| JR6-L3150 |
160334-13-4 |
[1,1'-Binaphthalen]-2-ol, 6,6'-dibromo-2'-methoxy-, (R)- (9CI) |
|
| JR6-L3156 |
144970-05-8 |
[1,1'-Binaphthalene]-3-carboxaldehyde, 2-hydroxy-2'-methoxy- |
|
| JR6-L3159 |
1000701-63-2 |
[1,1'-Binaphthalen]-2-ol, 2'-methoxy-3,3'-diphenyl-, (1S)- |
|
| JR6-L3218 |
134532-03-9 |
[1,1'-Binaphthalen]-2-ol, 2'-amino- |
|
| JR6-L3224 |
75740-88-4 |
1,1'-Binaphthalene, 2,2'-dimethoxy-3,3'-dimethyl-, (1R)- (9CI) |
|
| JR6-L4156 |
269396-77-2 |
Benzenebutanoic acid, ß-[[(1,1-dimethylethoxy)carbonyl]amino]-2-(trifluoromethyl)-, (ßR)- |
|
| JR6-L4171 |
269398-93-8 |
Benzenebutanoic acid, ß-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3,4,5,6-pentafluoro-, (ßR)- |
|
| JR6-L4176 |
775354-19-3 |
Benzenebutanoic acid, ß-[[(1,1-dimethylethoxy)carbonyl]amino]-2-fluoro-5-(trifluoromethyl)-, (ßR)- |
|
| JR6-L4590 |
111512-37-9 |
1,7-Octadiene-4,5-diol |
|
| JR6-L4764 |
921760-77-2 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 6-(3-carboxyphenyl)-3,4-dihydro-4-oxo-, 1,1-dimethylethyl ester |
|
| JR6-L4779 |
956605-24-6 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1',7-dicarboxylic acid, 3,4-dihydro-4-oxo-, 1'-(1,1-dimethylethyl) 7-[(4-methoxyphenyl)methyl] ester |
|
| JR6-L4992 |
74205-05-3 |
Cyclopropanecarbonitrile, 1-(3-butoxyphenyl)- |
|
| JR6-L4997 |
1252641-79-4 |
Cyclopropanecarbonitrile, 1-(2,4-dichloro-5-fluorophenyl)- |
|
| JR6-L6396 |
183500-34-7 |
1H-Imidazole-4-methanol, 1-(triphenylmethyl)-, 4-acetate |
|
| JR6-L6415 |
1256956-11-2 |
3H-Imidazo[4,5-b]pyridine, 6-bromo-3-(triphenylmethyl)- |
|
| JR6-L6491 |
37141-32-5 |
2-Oxiranemethanol, 3-(4-nitrophenyl)-, (2R,3R)- |
|
| JR6-L6737 |
165190-76-1 |
4,7-di(thiophen-2-yl)benzo[c][1,2,5]thiadiazole |
|
| JR6-L8727 |
141339-40-4 |
2-Pentanol, 1-chloro-, (2S)- |
|
| JR8-N0035 |
16837-52-8 |
Oxymatrine |
|
| JR8-N0412 |
139051-27-7 |
Anemarsaponin B |
|
| JR8-N0417 |
2586-96-1 |
Liensinine |
|
| JR8-N1040 |
548-37-8 |
Verbenalin |
|
| JR8-N1049 |
110026-03-4 |
Taurohyodeoxycholic acid sodium salt hydrate |
|
| JR8-N1056 |
80321-69-3 |
Gypenoside XVII |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Comments |
| |
|
 |
|
|
|
|
|
|